CDH23 -Associated Usher Syndrome: Clinical Features, Retinal Imaging, and Natural History
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.8.27 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2024. Written by Thales A C de Guimaraes and 9 co-authors. Institution: UCL Institute of Ophthalmology, University College London, London, United Kingdom. Major MEDLINE topics: Usher Syndromes, Electroretinography, Visual Acuity, Tomography, Optical Coherence. Cited 13 times so far (Crossref); 43 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust.
Abstract (original language)
Purpose
The purpose of this study was to analyze the clinical spectrum and natural history of CDH23-associated Usher syndrome type ID (USH1D).
Methods
Molecularly-confirmed individuals had data extracted from medical records. Retinal imaging was extracted from an in-house database. The main outcome measurements were retinal imaging and electroretinography (ERG) and clinical findings, including age of onset, symptoms, best-corrected visual acuity (BCVA), outer nuclear layer (ONL) thickness, ellipsoid zone width (EZW), and hyperautofluorescent ring area.
Results
Thirty-one patients were identified, harboring 40 variants in CDH23 (10 being novel). The mean (range, ±SD) age of symptom onset was 10.1 years (range = 1-18, SD = ±4.1). The most common visual symptoms at presentation were nyctalopia (93.5%) and peripheral vision difficulties (61.3%). The mean BCVA at baseline was 0.25 ± 0.22 in the right eyes and 0.35 ± 0.58 LogMAR in the left eyes. The mean annual loss rate in BCVA was 0.018 LogMAR/year over a mean follow-up of 9.5 years. Individuals harboring the c.5237G>A p.(Arg1746Gln) allele had retinitis pigmentosa (RP) sparing the superior retina. Seventy-seven percent of patients had hyperautofluorescent rings in fundus autofluorescence. Full-field and pattern ERGs indicated moderate-severe rod-cone or photoreceptor dysfunction with relative sparing of macular function in most patients tested. Optical coherence tomography (OCT) revealed intraretinal cysts in the transfoveal B-scan of 13 individuals (43.3%). The rate of EZW and ONL thickness loss was mild and suggestive of a wide window of macular preservation.
Conclusions
Despite the early onset of symptoms, USH1D has a slowly progressive phenotype. There is high interocular symmetry across all parameters, making it an attractive target for novel therapies.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- UCL Institute of Ophthalmology, University College London, London, United Kingdom.
- Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
- Universidade Sao Leopoldo Mandic, Campinas, Sao Paulo, Brazil.
- Eye Center, Faculty of Medicine, University Freiburg, Germany.
Funding
- Wellcome Trust
Cite
APA
de Guimaraes, T. A. C., Robson, A. G., de Guimaraes, I. M. C., Laich, Y., Aychoua, N., Wright, G., Kalitzeos, A., Mahroo, O. A., Webster, A. R., & Michaelides, M. (2024). CDH23 -Associated Usher Syndrome: Clinical Features, Retinal Imaging, and Natural History. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.8.27
Vancouver
de Guimaraes TAC, Robson AG, de Guimaraes IMC, Laich Y, Aychoua N, Wright G, et al. CDH23 -Associated Usher Syndrome: Clinical Features, Retinal Imaging, and Natural History. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.8.27
BibTeX
@article{deGuimaraes2024,
author = {de Guimaraes, Thales A C and Robson, Anthony G and de Guimaraes, Isabela M C and Laich, Yannik and Aychoua, Nancy and Wright, Genevieve and Kalitzeos, Angelos and Mahroo, Omar A and Webster, Andrew R and Michaelides, Michel},
title = {CDH23 -Associated Usher Syndrome: Clinical Features, Retinal Imaging, and Natural History},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.8.27}
}
EUVIMED